Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Catalysis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel synthesis of phosphotrog base ligand reduces cost and waste significantly. Reliable supply for catalytic applications in pharmaceutical manufacturing processes globally.
Patent CN107382867B reveals a robust 3-step synthesis for 4-isothiocyanatopyrazolones, enabling cost-effective production of hCE1 inhibitor precursors.
Patent CN100404686C details enzymatic resolution of C-24 hydroxy vitamin D isomers, offering cost reduction in API manufacturing and reliable supply chain solutions.
Patent CN115976130A reveals a novel enzymatic route for Rimegepant intermediate VI, achieving 90.1% yield and superior impurity control for reliable pharmaceutical supply chains.
Patent CN111349677B details high-purity steroid intermediate synthesis using recombinant enzymes for cost-effective pharmaceutical manufacturing supply chains and reduced environmental impact.
Novel boric acid-catalyzed route for 4,4-dichlorodiphenyl sulfone. Low temperature, high purity, reduced isomers. Ideal for pharma and polymer industries.
Novel patent CN106188047B details high-yield synthesis of moxifloxacin intermediate. Offers cost reduction and supply chain reliability for pharmaceutical manufacturers seeking scalable solutions.
Patent CN112094182A reveals a green molecular sieve catalyzed route for benzocyclohexanones, offering cost reduction and supply chain reliability for API manufacturing.
Novel enzyme process for cefoxitin acid reduces waste and energy. Reliable supply chain for high-purity pharmaceutical intermediates with scalable manufacturing capabilities.
Novel enzymatic method for L-2-aminobutyric acid production. Low cost, high yield, scalable process for pharmaceutical intermediates and supply chain optimization.
Novel aqueous catalytic method reduces cost and improves purity for luliconazole intermediate manufacturing ensuring supply chain stability.
Advanced synthesis of Remdesivir intermediates via optimized cyanation and ammonolysis. Reduces waste and improves scalability for pharmaceutical manufacturing.
Advanced enzymatic resolution synthesis for chiral antifungal intermediates. Cost-effective, scalable production of high-purity pharmaceutical ingredients with superior stereocontrol.
Patent CN115385873B details a continuous flow method for perfluoro-2,3-epoxy-2-methylpentane using oxygen oxidation, offering superior safety and yield for fluorine chemical manufacturing.
Patent CN103709179B details a high-purity Cefmetazole Sodium route using DCT. This report analyzes cost reduction and supply chain reliability for global buyers.
Patent CN113880901B reveals a metal-free asymmetric halocyclization route for high-purity nucleoside intermediates, offering significant cost reduction and supply chain reliability.
Patent CN108147973B details a novel thiourea-catalyzed route for ECPPA, offering superior stereoselectivity and simplified processing for ACE inhibitor manufacturing.
Novel acidic resin catalysis for Trifluridine intermediate. Enhances purity above 98 percent, reduces emulsification, ensures scalable supply for pharmaceutical manufacturing.
Advanced synthesis of Tiotropium Bromide using Na/NaOMe catalysis. Achieves <0.1% isomer impurity. Reliable API supplier for respiratory pharmaceuticals.
Patent CN103755554A details a novel cobalt-catalyzed Kumada coupling route for high-purity (S)-fenoprofen, offering significant cost reduction in NSAID manufacturing.